Szekeres David Leslie has filed 5 insider transactions across 1 company since August 2023.
Most recent transaction: a grant/award of 39897 shares of GRI Bio, Inc. ($GRI) on September 18, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 18, 2025 | GRI Bio, Inc. | $GRI | Szekeres David Leslie | Director | A | Stock Option (Right to Buy) | 39897 | $0.00 | 39,897.0000 | 2,496,800 | 9999.99% | 1.60% |
| Aug. 26, 2025 | GRI Bio, Inc. | $GRI | Szekeres David Leslie | Director | A | Stock Option (Right to Buy) | 10276 | $0.00 | 10,276.0000 | 2,496,800 | 9999.99% | 0.41% |
| Aug. 13, 2025 | GRI Bio, Inc. | $GRI | Szekeres David Leslie | Director | A | Stock Option (Right to Buy) | 7545 | $0.00 | 7,545.0000 | 2,496,800 | 9999.99% | 0.30% |
| Jan. 23, 2025 | GRI Bio, Inc. | $GRI | Szekeres David Leslie | Director | A | Stock Option (Right to Buy) | 51937 | $0.69 | 51,937.0000 | 525,485 | 9999.99% | 9.88% |
| Aug. 10, 2023 | GRI Bio, Inc. | $GRI | Szekeres David Leslie | Director | A | Stock Option (Right to Buy) | 34483 | $2.90 | 34,483.0000 | 646 | 9999.99% | 100.00% |